The US Food and Drug Administration is considering pulling the diet drug Meridia (sibutramine) off the market because of an increased risk of heart attack and strokes notes a story from the Associated Press. “Given the modest decrease in body weight associated with sibutramine and the potentially substantial weight regain with discontinuation of therapy, even a small increase in cardiovascular risk seems unwarranted,” states Dr. Simone Pinheiro, of the FDA’s epidemiology division. Earlier this month, the editors of the New England Journal of Medicine said that FDA should pull the drug off the market. European regulators pulled the product off the market in January.
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.